Cancer Prevention and Control
The Cancer Prevention and Control program covers the gamut from preventing cancer, particularly in high-risk groups, to conducting research in such areas as exercise oncology, health disparities, and geriatric oncology. Our focus is on improving treatment-related side effects and toxicities. Our success stems from being one of the first cancer control and population science programs in the nation.
Working directly with patients, survivors and caregivers, Wilmot’s CPC Program focuses its expertise and resources on the following specific aims:
- Identify interventions to reduce cancer risk for individuals with a high probability for a cancer diagnosis
- Develop effective supportive care therapies for patients, survivors, and caregivers to mitigate the toxicities and side effects caused by cancer and its treatments
- Develop effective system-level supportive care interventions for oncology practices and healthcare systems to improve cancer-care delivery and outcomes
Program Leaders
Supriya Mohile, M.D., M.S.
Philip and Marilyn Wehrheim Professor of Medicine, Hematology/Oncology
Dr. Mohile conducts research focused on improving cancer care delivery for older adults.
Karen Mustian, Ph.D., M.P.H.
Dean’s Professor of Surgery, Cancer Control
Dr. Mustian focuses on the role of physical activity and exercise on cancer- and treatment-related side effects.